Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.

NCT04526951 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04526951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04526951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
Lead sponsor
Oslo University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 30, 2020
Completion date
June 20, 2025
Enrollment
81 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal artery occlusion